Evidence map›Paper›PMID 28905080›Full record

ArticleDer Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen2018

[Treatment of retroperitoneal sarcoma in Germany : Results of a survey of the German Society of General and Visceral Surgery, the German Interdisciplinary Sarcoma Study Group and the advocacy group Das Lebenshaus].

J Jakob, A Gerres, U Ronellenfitsch, L Pilz, M Wartenberg, B Kasper, H-R Raab, P Hohenberger

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. [Systematic surgery of retroperitoneal sarcomas : Imaging-guided planning of surgical strategy].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2019
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

J JakobSpezielle Chirurgische Onkologie und Thoraxchirurgie, Chirurgische Klinik, Universitätsmedizin Mannheim, Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68137, Mannheim, Deutschland. Jens.jakob@umm.de.
A GerresMedizinische Fakultät Mannheim, Universität Heidelberg, Heidelberg, Deutschland.
U RonellenfitschKlinik für Gefäßchirurgie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.
L PilzMedizinische Fakultät Mannheim, Universität Heidelberg, Heidelberg, Deutschland.
M WartenbergDas Lebenshaus, Wölfersheim, Deutschland.
B KasperInterdisziplinäres Tumorzentrum Mannheim, Universitätsmedizin Mannheim, Universität Heidelberg, Heidelberg, Deutschland.
H-R RaabUniversitätsklinik für Allgemein- und Viszeralchirurgie, Klinikum Oldenburg, Oldenburg, Deutschland.
P HohenbergerSpezielle Chirurgische Onkologie und Thoraxchirurgie, Chirurgische Klinik, Universitätsmedizin Mannheim, Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68137, Mannheim, Deutschland.
Heidelberg University · DEChirurgische Universitätsklinik Heidelberg · DEKlinikum Oldenburg · DEMedizinische Fakultät Mannheim

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveRetroperitoneal sarcomas (RPSs) are rare cancers with some variability in clinical and histopathological presentation. In Germany, general treatment strategies of retroperitoneal sarcoma are unknown since centralized registries do not exist. The objective of this survey was to access the medical care of RPS patients in Germany.

methodsIn cooperation with the German Society of General and Visceral surgery, the German Interdisciplinary Sarcoma Study Group and the patient advocacy group Das Lebenshaus we designed an online survey assessing diagnostic and treatment strategies (e. g. performance of tumor biopsies, administration of multimodal therapies and surgical strategy). All departments for general and visceral surgery in Germany were addressed (n = 976).

resultsResponses were received from 191 of 976 departments. Only 11 surgical departments treat more than 10 RPS patients per year. A multidisciplinary sarcoma board exists in 19 hospitals. Staging is generally performed by cross-sectional imaging. In 54% of the departments pretreatment tumor biopsy is a standard procedure. Surgery is performed as compartment resection in 85% of the departments. A systematic lymph node dissection is done in 40%. Adjuvant radio- or chemotherapy is performed as a standard treatment in 27% and 22% departments, respectively.

conclusionThe survey demonstrates a large heterogeneity in RPS diagnostic and treatment strategies. Dedicated education programs and centralized treatment strategies are warranted to improve the standard of care.

Indexed as

Retroperitoneal NeoplasmsSarcomaGermanyHumansSurveys and QuestionnairesMultimodal therapyMultivisceral resectionRetroperitoneal sarcomaStandard of careSurvey

Identifiers

PMID28905080
OpenAlexW2756396909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.